Clinical Trials Directory

Trials / Unknown

UnknownNCT02737150

SecOnd-generation seLf-expandable Versus Balloon-expandable Valves and gEneral Versus Local Anesthesia in TAVI

CompariSon of secOnd-generation seLf-expandable Versus Balloon-expandable Valves and gEneral Versus Local Anesthesia in Transcatheter Aortic Valve Implantation (SOLVE-TAVI)

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
444 (actual)
Sponsor
Helios Health Institute GmbH · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Aim of the study is to demonstrate equivalence of second-generation self-expandable valves (CoreValve Evolut R) in comparison to second-generation balloon-expandable valves (Edwards Sapien 3) and of local anesthesia with conscious sedation in comparison to general anesthesia with respect to safety and efficacy in high-risk patients with severe aortic stenosis undergoing transcatheter aortic valve implantation.

Conditions

Interventions

TypeNameDescription
DEVICECoreValve Evolut R
DEVICEEdwards Sapien 3
PROCEDURELocal anesthesia with conscious sedation
PROCEDUREGeneral anesthesia

Timeline

Start date
2016-04-01
Primary completion
2019-02-01
Completion
2021-04-01
First posted
2016-04-13
Last updated
2021-02-18

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT02737150. Inclusion in this directory is not an endorsement.